Amino acid availability governs mTOR ubiquitination

Cell Res. 2024 May;34(5):335-336. doi: 10.1038/s41422-023-00910-3.

Authors

Xiaoming Dai¹, Peiqiang Yan², Wenyi Wei³

Affiliations

¹ Department of Pathology, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA, USA. xdai1@bidmc.harvard.edu.
² Department of Pathology, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA, USA.
³ Department of Pathology, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA, USA. wwei2@bidmc.harvard.edu.

PMID: 38102197
PMCID: PMC11061116 (available on 2025-05-01)
DOI: 10.1038/s41422-023-00910-3

No abstract available

Publication types

Letter
Research Support, Non-U.S. Gov't

MeSH terms

Amino Acids* / metabolism
Animals
Humans
TOR Serine-Threonine Kinases* / metabolism
Ubiquitination*

Substances

TOR Serine-Threonine Kinases
Amino Acids
MTOR protein, human

Grants and funding